Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease
M Alexander(Christian Medical College & Hospital), William Alazawi(Queen Mary University of London)
Cited by 272
Related Papers
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
A global action agenda for turning the tide on fatty liver disease
|Hepatology|2023|90
(untitled)
|Discovery Research Portal (University of Dundee)|2022|62
An Expert Consensus Delphi Panel in Metabolic Dysfunction- and Alcohol-associated Liver Disease: Opportunities and Challenges in Clinical Practice
|Clinical Gastroenterology and Hepatology|2025|16